In this month's trial, which began on Aug. 28, Eric Olson ( Olson Grimsley) and Ashley Keller ( Keller Postman) represented ...

On Wednesday, a jury in Cook County Circuit Court in Illinois ended in a mistrial in a case against Zantac manufacturer ...

The latest trial over claims that the discontinued heartburn drug Zantac causes cancer ended with a hung jury on Wednesday, ...

The latest trial over claims that the discontinued heartburn drug Zantac causes cancer ended with a hung jury on Wednesday, ...

Since 2019, there have been 15 peer-reviewed epidemiological studies on the effects of ranitidine use on humans which reflect the scientific consensus that there is no consistent or reliable ...

Drug maker GSK plc (GSK, GSK.L) confirmed Wednesday that it has reached two confidential settlements in cases filed in California ...

GSK said in a statement that since the potential link between ranitidine, NDMA and cancer first emerged in 2019, there have been 13 peer-reviewed epidemiological studies looking at the use of the ...

Since 2019, there are 16 epidemiological studies looking at human data regarding the use of ranitidine, including outcomes for more than 1million patients using ranitidine, supporting this consensus.' ...

No such relationship existed. The human studies didn’t show a consistent statistically significant and valid association between ranitidine use and cancer, let alone causation. Based on these ...

These include challenging plaintiffs' proof of ranitidine use and cancer diagnosis, as recently mandated by the court. GSK's commitment to vigorously defend itself aligns with its broader mission ...

GSK emphasised that the scientific consensus, supported by 16 epidemiological studies involving over a million patients, did not establish a reliable link between ranitidine and cancer.